BIOMIMETIC THERAPEUTICS, INC.

Q: Sep 30 2012

Q: Jun 30 2012

Q: Mar 31 2012

FY: Dec 31 2011

Q: Sep 30 2011

Q: Jun 30 2011

Q: Mar 31 2011

FY: Dec 31 2010

FY: Dec 31 2010

FY: Dec 31 2010

Q: Sep 30 2010

Q: Jun 30 2010

Q: Mar 31 2010

FY: Dec 31 2009

Q: Mar 31 2010

FY: Dec 31 2009

Q: Sep 30 2009

Q: Jun 30 2009

Q: Mar 31 2009

FY: Dec 31 2008

2.01,3.01,3.03,5.01,5.02,9.01

5.07

8.01

8.01

8.01

8.01

8.01,9.01

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

1.01,5.02,8.01,9.01

2.02,9.01

Other Events

2.02,9.01

8.01,9.01

8.01,9.01

5.05,5.07,8.01,9.01

Results of Operations and Financial Condition

5.02

Results of Operations and Financial Condition

5.02

1.01,9.01

Notice of Effectiveness

Certification of termination of registration of a class of securities (Section 12(g))

Notice of Effectiveness

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Notification of removal from listing and/or registration on a national securities exchange

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Additional Information for Proxy Statement/ Votes

No description available

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Required Information in Proxy Statement

Required Information in Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

AQR CAPITAL MANAGEMENT LLC

WATSON DOUGLAS G

INTERWEST PARTNERS VIII LP

Christensen Thorkil K.

Novo A/S

FEDERICO CHARLES

Lynch Samuel Eugene

BULLOCK LAWRENCE E

PAPASAN LARRY W

WATSON DOUGLAS G

MURPHY JAMES G

Pagano Russell P.

Friedlaender Gary E

Ehrlich Christopher B

AQR CAPITAL MANAGEMENT LLC

Clearbridge Investments, LLC

Pagano Russell P.

INTERWEST PARTNERS VIII LP

Novo A/S

WRIGHT MEDICAL GROUP INC

Annual reports of employee stock purchase savings and similar plans pursuant to Section 15(d)

No description available

No description available

Annual reports of employee stock purchase savings and similar plans pursuant to Section 15(d)

No description available

Letter from the SEC

No description available

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

No description available

Annual reports of employee stock purchase savings and similar plans pursuant to Section 15(d)

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC